Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 102,685 | 69,399 | 127,704 | 58,215 | 110,891 |
| Marketable Securities | 578,276 | 367,272 | 395,410 | 162,064 | 292,735 |
| Other current assets | 4,973 | 4,184 | 7,514 | 7,104 | 4,033 |
| TOTAL | $695,471 | $450,062 | $541,650 | $237,899 | $416,472 |
| Non-Current Assets | |||||
| PPE Net | 386,032 | 375,911 | 359,252 | 333,411 | 290,262 |
| Intangibles | 8,562 | 8,987 | 9,412 | 9,837 | 10,262 |
| Other Non-Current Assets | 49,737 | 48,799 | 44,836 | 45,139 | 48,556 |
| TOTAL | $444,331 | $433,697 | $413,500 | $388,387 | $349,080 |
| Total Assets | $1,139,802 | $883,759 | $955,150 | $626,286 | $765,552 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,388 | 26,550 | 8,521 | 4,460 | 35,866 |
| Accrued Expenses | 85,006 | 63,694 | 50,796 | 55,381 | 57,726 |
| Other current liabilities | 432 | 417 | 573 | 461 | 435 |
| TOTAL | $103,168 | $96,714 | $65,175 | $63,723 | $105,456 |
| Non-Current Liabilities | |||||
| Long Term Debt | 393,183 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 866 |
| Other Non-Current Liabilities | 455,196 | 451,255 | 396,266 | 391,361 | 374,270 |
| TOTAL | $845,571 | $448,071 | $394,570 | $388,849 | $372,934 |
| Total Liabilities | $948,739 | $544,785 | $459,745 | $452,572 | $478,390 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 124,434 | 124,315 | 124,200 | 123,897 | 107,432 |
| Common Shares | 217 | 217 | 217 | 200 | 200 |
| Retained earnings | -1,625,523 | -1,454,987 | -1,284,194 | -1,158,894 | -1,026,030 |
| Other shareholders' equity | 10,369 | 7,440 | 10,516 | 12,052 | 12,597 |
| TOTAL | $191,063 | $338,974 | $495,405 | $173,714 | $287,162 |
| Total Liabilities And Equity | $1,139,802 | $883,759 | $955,150 | $626,286 | $765,552 |